Draegerwerk AG & Co. KGaA · XETR:DRW8
Draegerwerk AG & Co. KGaA — Drägerwerk AG & Co. KGaA — Q1 2005 Earnings Presentation
16 slides from Draegerwerk AG & Co. KGaA's earnings presentation, May 12, 2005
Slide 1: Drägerwerk AG Conference Call
Drägerwerk AG »Technology for Life« Conference Call May 12, 2005 1 Mai, 05
Slide 2: Highlights 1st Quarter 2005 – Dräger Medical
Highlights 1st Quarter 2005 DRÄGER MEDICAL • Operating order entry and net sales double-digit above previous year - USA starts with order entry plus 20.5 % • Increase of net profit above average • Innovation push continues - Infinity® OneNet, a breakthrough capability that lets hospitals run wired a
Slide 3: Q1-Report Dräger Medical
Q1-Report Dräger Medical (01.01.- 31.03.2005, IFRS) SALES AND EARNINGS/ mn € Q1/2005 Q1/ 2004 Change Order entry 263.8 221.2 + 19.3% Net sales 226.2 200.2 + 13.0% Operating EBIT * 11.9 10.0 + 19.0% Operating EBIT margin 5.3% 5.0% Capital employed 561.7 458.4 + 22.5% Net debt -138.1 -184.9 - 25.3% 1)
Slide 4: Highlights 1st Quarter 2005 – Dräger Safety
Highlights 1st Quarter 2005 DRÄGER SAFETY • Growth mainly based on volume business • Integration of Dräger Interservices GmbH • Regional sales trend - America + 5.1 % (currency adjusted) - Asia/Pacific - 13.7 % (currency adjusted, 2004: SARS-effected) - Europe + 11.2 % • Expenses for R&D continuousl
Slide 5: Q1-Report Dräger Safety
Q1-Report Dräger Safety (01.01.- 31.03.2005, IFRS) SALES AND EARNINGS/ mn € Q1/2005 Q1/2004 Change Order entry 136.4 1) 132.8 + 2.7% Net sales 123.2 1) 113.3 + 8.7% Operating EBIT 11.1 2) 9.6 + 15.6% Operating EBIT margin 9.0% 8.5% Capital employed 176.0 155.8 + 13.0% Net debt 22.8 13.9 + 64.0% 1) I
Slide 6: Q1-Report Dräger Group
Q1-Report Dräger Group (01.01.- 31.03.2005, IFRS) SALES AND EARNINGS/ mn € Q1/2005 Q1/2004 Change Order entry 392.5 351.4 + 11.7% Net sales 341.4 312.8 + 9.1% Operating EBIT 18.0 17.8 + 1.1% EBIT margin 5.3% 5.7% Net income 4.9 15.7 1) - 68.8% Capital employed 803.9 678.0 + 18.6% Net debt 221.0 104.
Slide 7: Q1-Report Dräger Group – Sales and Earnings
Q1-Report Dräger Group (01.01.- 31.03.2005, IFRS) SALES AND EARNINGS/ mn € Q1/2005 Q1/2004 +/- Order entry 392.5 351.4 + 11.7% Net sales 341.4 312.8 + 9.1% Cost of goods sold (COGS) -171.4 -148.5 + 15.4% Gross profit 170.0 164.3 + 3.5% Gross margin 49.8% 52.5% - 5.2% Functional cost -151.4 -147.2 +
Slide 8: Consolidated Balance Sheet – Assets
Q1-Report Dräger Group Key Figures/ Consolidated Balance Sheet (IFRS) ASSETS/ mn € 31.03.2005 31.12.2004 Intangible assets 175.8 176.5 Property, plant and equipment 189.5 189.2 Other noncurrent assets 24.7 30.4 Deferred taxes 80.2 76.9 Noncurrent assets 470.2 473.0 Inventories 293.2 260.4 Trade rece
Slide 9: Consolidated Balance Sheet – Equity and Liabilities
Q1-Report Dräger Group Key Figures/ Consolidated Balance Sheet (IFRS) EQUITY AND LIABILITIES/ mn € 31.03.2005 31.12.2004 Equity 487.7 477.3 Participation capital 74.8 74.8 Pension provisions 156.2 155.5 Other noncurrent provisions and liabilities 132.2 131.9 Deferred taxes 17.0 16.7 Noncurrent liabi
Slide 10: Outlook
Q1-Report Dräger Group Outlook mn € 31.12.2004 Guidance 2005 Dräger Medical Net sales 1,023 + 5-7 % Operating EBIT 94 + 5-10 % Dräger Safety Net sales 503 + 5-7 % Operating EBIT 41 + 5-10 % Dräger Konzern Net sales 1,521 + 5-7 % Operating EBIT 117 + 5-10 % Net profit 47 + 5-10 % 10 Mai, 05
Slide 11: Appendix
Appendix 11 Mai, 05
Slide 12: Reconciliation of Equity by March 31, 2004
Q1-Bericht Dräger Konzern Reconciliation of Equity by March 31, 2004 mn € 31.03.2004 Equity under HGB (incl. minority interests) 514.3 Asset-backed securities -2.6 Recognition of internally developed Software 2.4 Goodwill 1.8 Valuation adjustment of components/ adjustment of depreciation -1.8 Recogn
Slide 13: Reconciliation of Net Income by March 31, 2004
Q1-Bericht Dräger Konzern Reconciliation of Net Income by March 31, 2004 mn € 31.03.2004 Net income under HGB (incl. minority interests) 13.4 Recognition of internally developed Software -0.2 Valuation adjustment of components/ adjustment of depreciation -0.1 Inventory measurement 3.1 Adjustment of
Slide 14: Reconciliation of Equity by December 31, 2003
Dräger Group Reconciliation of Equity by December 31, 2003 mn € 01.01.2003 31.12.2003 Equity under HGB (incl. minority interests) 170.133 499.182 Asset-backed securities -2.677 -2.618 Recognition of internally developed software 2.983 2.607 Goodwill -3.214 115 Valuation adjustment of components/adju
Slide 15: Reconciliation of Net Income by December 31, 2003
Dräger Group Reconciliation of Net Income by December 31, 2003 mn € 2003 Net income under HGB (incl. minority interests) 37.807 Recognition/valuation adjustment of internally developed software -376 Goodwill 666 Valuation adjustment of components/adjustment of depreciation -428 Recognition of financ
Slide 16: Disclaimer
Disclaimer Estimates: This presentation contains a number of forecasts and estimates which are based on present expectations, anticipations and predictions on the part of the Executive Board and the information it currently has. Such estimates should not be construed as a warranty that the future de
Drägerwerk AG & Co. KGaA — Q1 2005 Earnings Presentation on 6ix